Global Osteoarthritis Drugs Market 2020 By Drug Class [Corticosteroids, NSAIDs, Viscosupplementation Agents and others],By Route of Administration [Topical, Parenteral and Oral], By Distribution Channel[Hospital Pharmacies, Online Pharmacies and Retail Pharmacies]: Global Forecast to 2026 and COVID-19 Impact Outlook

Global Osteoarthritis Drugs Market is valued at USD 6.44 Billion in 2019 and expected to reach USD 10.88 Billion by 2026 with the CAGR of 7.8 % over the forecast period.

Scope of the report

This report analyses the global market for Osteoarthritis Drugs. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.

Key Players

Alkem Laboratories, Anika Therapeutics, Inc., Bioventus, Inc., Chugai Pharmaceutical Co., Limited, Ferring B.V., Flexion Therapeutics, Inc., Horizon Pharma plc, Pfizer Inc., Sanofi, Zimmer Biomet Holdings, Inc, and others

Above mentioned companies were scrutinized to assess competitive landscape of global Osteoarthritis Drugs market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.

Review period: (2016-2026)

Historic Period: 2016 to 2019

Forecast Period: 2020 to 2026

Base Year: 2019

Unit: USD Billion

This Osteoarthritis Drugs market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.

Regions

• North America: U.S., Canada and Rest of North America

• Europe: UK, France, Germany, Italy, Spain and Rest of Europe

• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific

• Latin America: Brazil, Mexico, Argentina and Rest of Latin America

• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa

Market Segmentation

• Drug Class

o Corticosteroids

o NSAIDs

o Viscosupplementation Agents

• Route of Administration

o Topical

o Parenteral

o Oral

• Distribution Channel

o Hospital Pharmacies

o Online Pharmacies

o Retail Pharmacies

Report Coverage

• An overview of the global Osteoarthritis Drugs market

• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market

• Global Osteoarthritis Drugs market revenue data historic and forecast analysis (2016 to 2026)

• Characterization and quantification of the market segments for Osteoarthritis Drugs market

• Market share analysis of key market participants and their competitive landscape

Important Questions Answered by Global Osteoarthritis Drugs Market Report

• What is the impact of COVID 19 epidemic on the global Osteoarthritis Drugs market

• Which is mostly affected region, country

• Which is the current largest and fastest-growing region

• What is the market size and growth rate of the global Osteoarthritis Drugs market

• What are current factors affecting the growth of market

• What are Key trends and opportunity areas

• Within Osteoarthritis Drugs market, which segments are fastest growing & emerging strongly What are the drivers and restraints for each segment What are vendor competencies by segment

• What are the major strategies adopted by leading market companies

• What are company challenges and essential success factors by marketsegment

• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs

1. Introduction

1.1. Report Description

1.2. Market Segmentation

1.3. Research Methodology

1.4. List of Abbreviations

2. Executive Summary

3. Market Overview

3.1. Market Definition

3.2. Market Scope

3.3. Market Drivers

3.4. Market Restraints

3.5. Market Opportunities and Trends

3.6. Porter’s five force analysis

3.7. SWOT Analysis

3.8. PEST Analysis

3.9. Patent Analysis

3.10. Impact of COVID 19 on Global Osteoarthritis Drugs Market

4. Osteoarthritis Drugs Market, By Drug Class, Market Size and Forecast 2016 -2026 (USD Billion)

4.1. Global Osteoarthritis Drugs Market By Drug Class, 2016 -2026 (USD Billion)

4.1.1. Global Osteoarthritis Drugs Market By Corticosteroids

4.1.2. Global Osteoarthritis Drugs Market By NSAIDs

4.1.3. Global Osteoarthritis Drugs Market By Viscosupplementation Agents

4.2. Global Osteoarthritis Drugs Market By Drug Class Share, 2016 -2026 (%)

5. Osteoarthritis Drugs Market, By Distribution Channel, Market Size and Forecast 2016 -2026 (USD Billion)

5.1. Global Osteoarthritis Drugs Market By Distribution Channel, 2016 -2026 (USD Billion)

5.1.1. Global Osteoarthritis Drugs Market By Hospital Pharmacies

5.1.2. Global Osteoarthritis Drugs Market By Online Pharmacies

5.1.3. Global Osteoarthritis Drugs Market By Retail Pharmacies

5.2. Global Osteoarthritis Drugs Market By Distribution Channel Share, 2016 -2026 (%)

6. Osteoarthritis Drugs Market, By Route of Administration, Market Size and Forecast 2016 -2026 (USD Billion)

6.1. Global Osteoarthritis Drugs Market By Route of Administration, 2016 -2026 (USD Billion)

6.1.1. Global Osteoarthritis Drugs Market By Topical

6.1.2. Global Osteoarthritis Drugs Market By Parenteral

6.1.3. Global Osteoarthritis Drugs Market By Oral

6.2. Global Osteoarthritis Drugs Market By Route of Administration Share, 2016 -2026 (%)

7. Osteoarthritis Drugs Market, By Region Market Size and Forecast 2016 -2026

7.1. NORTH AMERICA

7.1.1. Key Findings

7.1.2. Impact of COVID 19

7.1.3. Key market trends, growth factors and opportunities

7.1.4. North America Osteoarthritis Drugs Market by Country 2016 -2026 (USD Billion)

7.1.5. North America Osteoarthritis Drugs Market By Drug Class 2016 -2026 (USD Billion)

7.1.6. North America Osteoarthritis Drugs Market By Route of Administration 2016 -2026 (USD Billion)

7.1.7. North America Osteoarthritis Drugs Market By Distribution Channel 2016 -2026 (USD Billion)

7.2. EUROPE

7.2.1. Key Findings

7.2.2. Impact of COVID 19

7.2.3. Key market trends, growth factors and opportunities

7.2.4. Europe Osteoarthritis Drugs Market by Country 2016 -2026 (USD Billion)

7.2.5. Europe Osteoarthritis Drugs Market By Drug Class 2016 -2026 (USD Billion)

7.2.6. Europe Osteoarthritis Drugs Market By Route of Administration 2016 -2026 (USD Billion)

7.2.7. Europe Osteoarthritis Drugs Market By Distribution Channel 2016 -2026 (USD Billion)

7.3. ASIA PACIFIC

7.3.1. Key Findings

7.3.2. Impact of COVID 19

7.3.3. Key market trends, growth factors and opportunities

7.3.4. Asia Pacific Osteoarthritis Drugs Market by Country 2016 -2026 (USD Billion)

7.3.5. Asia Pacific Osteoarthritis Drugs Market By Drug Class 2016 -2026 (USD Billion)

7.3.6. Asia Pacific Osteoarthritis Drugs Market By Route of Administration 2016 -2026 (USD Billion)

7.3.7. Asia Pacific Osteoarthritis Drugs Market By Distribution Channel 2016 -2026 (USD Billion)

7.4. LATIN AMERICA

7.4.1. Key Findings

7.4.2. Impact of COVID 19

7.4.3. Key market trends, growth factors and opportunities

7.4.4. Latin America Osteoarthritis Drugs Market by Country 2016 -2026 (USD Billion)

7.4.5. Latin America Osteoarthritis Drugs Market By Drug Class 2016 -2026 (USD Billion)

7.4.6. Latin America Osteoarthritis Drugs Market By Route of Administration 2016 -2026 (USD Billion)

7.4.7. Latin America Osteoarthritis Drugs Market By Distribution Channel 2016 -2026 (USD Billion)

7.5. MIDDLE EAST AND AFRICA

7.5.1. Key Findings

7.5.2. Impact of COVID 19

7.5.3. Key market trends, growth factors and opportunities

7.5.4. Middle East and Africa Osteoarthritis Drugs Market by Country 2016 -2026 (USD Billion)

7.5.5. Middle East and Africa Osteoarthritis Drugs Market By Drug Class 2016 -2026 (USD Billion)

7.5.6. Middle East and Africa Osteoarthritis Drugs Market By Route of Administration 2016 -2026 (USD Billion)

7.5.7. Middle East and Africa Osteoarthritis Drugs Market By Distribution Channel 2016 -2026 (USD Billion)

8. Competitive Landscape Analysis

8.1. Global Osteoarthritis Drugs Market Company Revenue, (USD Billion), 2016-2019

8.2. Global Osteoarthritis Drugs Market Company Share, (%), 2016-2019

9. Company Profiles

9.1. Alkem Laboratories

9.2. Anika Therapeutics, Inc.

9.3. Bioventus, Inc.

9.4. Chugai Pharmaceutical Co., Limited

9.5. Ferring B.V.

9.6. Flexion Therapeutics, Inc.

9.7. Horizon Pharma plc

9.8. Pfizer Inc.

9.9. Sanofi

9.10. Zimmer Biomet Holdings, Inc.

9.11. Others

10. Appendix

11. List of Tables

12. List of Figures

Methodology/Research Approach

Research Programs/Design

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources